Sara Bagherzadeh

Dr. Sara Bagherzadeh

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
MJMahboobeh Jafari
Mahboobeh Jafari
ASAfshin Shoeibi
Afshin Shoeibi
MKMarjaneh Khodatars
Marjaneh Khodatars
SBSara Bagherzadeh
Sara Bagherzadeh
ASAhmad Shalbaf
Ahmad Shalbaf
UAU. Rajendra Acharya
U. Rajendra Acharya

9 January 2022 in Cognitive Neurodynamics
Verified
Journal Article
Closed access
PDF file
SBSara Bagherzadeh
Sara Bagherzadeh
KMKeivan Maghooli
Keivan Maghooli
ASAhmad Shalbaf
Ahmad Shalbaf
AMArash Maghsoudi
Arash Maghsoudi

2 April 2024 in IEEE Access
Verified
Journal Article
Open access
SBSara Bagherzadeh
Sara Bagherzadeh
ASAhmad Shalbaf
Ahmad Shalbaf
ASAfshin Shoeibi
Afshin Shoeibi
MJMahboobeh Jafari
Mahboobeh Jafari
RTRu-San Tan
Ru-San Tan
UAU. Rajendra Acharya
U. Rajendra Acharya
The objective of this paper is to develop a novel emotion recognition system from electroencephalogram (EEG) signals using effective connectivity and deep learning methods. Emotion recognition is an important task for various applications such as human-computer interaction and, mental health diagnosis. The paper aims to improve the accuracy and robustness of emotion recognition by combining different effective connectivity (EC) methods and pre-trained convolutional neural networks (CNNs), as well as long short-term memory (LSTM). EC methods measure information flow in the brain during emotional states using EEG signals. We used three EC methods: transfer entropy (TE), partial directed coherence (PDC), and direct directed transfer function (dDTF). We estimated a fused image from these methods for each five-second window of 32-channel EEG signals. Then, we applied six pre-trained CNNs to classify the images into four emotion classes based on the two-dimensional valence-arousal model. We used the leave-one-subject-out cross-validation strategy to evaluate the classification results. We also used an ensemble model to select the best results from the best pre-trained CNNs using the majority voting approach. Moreover, we combined the CNNs with LSTM to improve recognition performance. We achieved the average accuracy and F-score of 98.76%, 98.86%, 98.66 and 98.88% for classifying emotions using DEAP and MAHNOB-HCI datasets, respectively. Our results show that fused images can increase the accuracy and that an ensemble and combination of pre-trained CNNs and LSTM can achieve high accuracy for automated emotion recognition. Our model outperformed other state-of-the-art systems using the same datasets for four-class emotion classification.



9 March 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
HESAM AKBARIHESAM AKBARI
HESAM AKBARI
SBSara Bagherzadeh
Sara Bagherzadeh
JSJavid Farhadi Sedehi
Javid Farhadi Sedehi
Rab NawazRab Nawaz
Rab Nawaz
RRReza Rostami
Reza Rostami
MMMutlu Mete
Mutlu Mete
Background/Objectives: Predicting individual response to depression therapy prior to treatment initiation remains a critical clinical challenge, as the response rate to both selective serotonin reuptake inhibitors (SSRIs) and repetitive transcranial magnetic stimulation (rTMS) is approximately 50%, leaving treatment selection largely trial-based. This study presents a computer-aided decision (CAD) framework that predicts depression therapy outcomes from pre-treatment electroencephalogram (EEG) signals using advanced time-frequency representations and pretrained convolutional neural networks (CNNs). Methods: EEG signals from 30 SSRI patients and 46 rTMS patients are transformed into time-frequency images using Continuous Wavelet Transform (CWT), Variational Mode Decomposition (VMD), and their pixel-level fusion. Four pretrained CNN architectures, including ResNet-18, MobileNet-V3, EfficientNet-B0, and TinyViT-Hybrid, are fine-tuned and evaluated under both image-independent and subject-independent 6-fold cross-validation (CV). Results: Results reveal a clear therapy-specific pattern: CWT-based representations yield superior discrimination for SSRI outcome prediction, with ResNet-18 achieving 99.43% image-level accuracy, while VMD-based representations are statistically superior for rTMS outcome prediction, with ResNet-18 reaching 98.77%. Pixel-level fusion of CWT and VMD does not consistently improve performance over the best individual representation in either therapy context. Pairwise Wilcoxon signed-rank tests confirm a two-tier architectural hierarchy in which ResNet-18 and TinyViT-Hybrid significantly outperform MobileNet-V3 and EfficientNet-B0 across all conditions, while remaining statistically indistinguishable from each other. At the subject level, the framework achieves 82.50% and 83.53% accuracy for SSRI and rTMS, respectively, under strict subject-independent evaluation. Per-channel analysis reveals occipital dominance for SSRI under CWT and frontotemporal dominance for rTMS under VMD, consistent with known neurophysiological mechanisms. Conclusions: These findings demonstrate that the choice of time-frequency representation is therapy-specific and at least as important as architectural complexity, and that competitive performance can be achieved without recurrent or attention layers by combining well-designed spectral images with a simple pretrained residual network.